Baker Bros. Advisors as of June 30, 2018
Portfolio Holdings for Baker Bros. Advisors
Baker Bros. Advisors holds 119 positions in its portfolio as reported in the June 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Seattle Genetics | 25.5 | $3.4B | 51M | 66.39 | |
| Incyte Corporation (INCY) | 17.2 | $2.3B | 34M | 67.00 | |
| Beigene (BGNE) | 13.8 | $1.8B | 12M | 153.73 | |
| Alexion Pharmaceuticals | 8.0 | $1.1B | 8.6M | 124.15 | |
| BioMarin Pharmaceutical (BMRN) | 5.4 | $714M | 7.6M | 94.20 | |
| Genomic Health | 5.2 | $695M | 14M | 50.40 | |
| ACADIA Pharmaceuticals (ACAD) | 3.1 | $416M | 27M | 15.27 | |
| Madrigal Pharmaceuticals (MDGL) | 2.5 | $327M | 1.2M | 279.69 | |
| Heron Therapeutics (HRTX) | 1.5 | $195M | 5.0M | 38.85 | |
| Ascendis Pharma A S (ASND) | 1.4 | $189M | 2.8M | 66.52 | |
| Mirati Therapeutics | 0.9 | $124M | 2.5M | 49.30 | |
| Spark Therapeutics | 0.9 | $115M | 1.4M | 82.76 | |
| Dbv Technologies S A (DBVT) | 0.8 | $106M | 5.5M | 19.29 | |
| Sage Therapeutics (SAGE) | 0.7 | $96M | 613k | 156.53 | |
| Array BioPharma | 0.7 | $95M | 5.7M | 16.78 | |
| Neurocrine Biosciences (NBIX) | 0.7 | $93M | 945k | 98.24 | |
| Rhythm Pharmaceuticals (RYTM) | 0.6 | $85M | 2.7M | 31.26 | |
| BioCryst Pharmaceuticals (BCRX) | 0.6 | $80M | 14M | 5.73 | |
| Argenx Se (ARGX) | 0.6 | $80M | 962k | 82.86 | |
| Cerus Corporation (CERS) | 0.5 | $72M | 11M | 6.67 | |
| Amarin Corporation (AMRN) | 0.5 | $70M | 23M | 3.09 | |
| Cymabay Therapeutics | 0.5 | $66M | 4.9M | 13.42 | |
| Invitae (NVTAQ) | 0.5 | $62M | 8.4M | 7.35 | |
| Kiniksa Pharmaceuticals (KNSA) | 0.4 | $52M | 3.0M | 17.35 | |
| Idera Pharmaceuticals | 0.4 | $51M | 39M | 1.32 | |
| Tricida | 0.4 | $48M | 1.6M | 29.90 | |
| Gw Pharmaceuticals Plc ads | 0.3 | $45M | 322k | 139.54 | |
| Novavax Inc note 3.750% 2/0 | 0.3 | $43M | 74M | 0.58 | |
| Abeona Therapeutics | 0.3 | $35M | 2.2M | 16.00 | |
| Erytech Pharma Sa | 0.3 | $35M | 3.1M | 11.17 | |
| Endocyte | 0.2 | $31M | 2.3M | 13.80 | |
| Bluebird Bio (BLUE) | 0.2 | $31M | 200k | 156.95 | |
| Xencor (XNCR) | 0.2 | $32M | 872k | 37.01 | |
| Bellicum Pharma | 0.2 | $30M | 4.1M | 7.38 | |
| Aquinox Pharmaceuticals | 0.2 | $29M | 11M | 2.65 | |
| Merus N V (MRUS) | 0.2 | $26M | 1.2M | 22.76 | |
| Galapagos Nv- (GLPG) | 0.2 | $24M | 260k | 92.18 | |
| Uniqure Nv (QURE) | 0.2 | $23M | 605k | 37.80 | |
| Halozyme Therapeutics (HALO) | 0.2 | $22M | 1.3M | 16.87 | |
| Myokardia | 0.2 | $22M | 433k | 49.65 | |
| Solid Biosciences | 0.2 | $21M | 588k | 35.63 | |
| Zymeworks | 0.1 | $19M | 1.3M | 14.78 | |
| Sangamo Biosciences (SGMO) | 0.1 | $18M | 1.3M | 14.20 | |
| Aimmune Therapeutics | 0.1 | $18M | 674k | 26.89 | |
| Insmed (INSM) | 0.1 | $17M | 700k | 23.65 | |
| Contrafect | 0.1 | $16M | 7.2M | 2.21 | |
| Clementia | 0.1 | $16M | 1.2M | 13.16 | |
| Intellia Therapeutics (NTLA) | 0.1 | $15M | 547k | 27.36 | |
| Aeglea Biotherapeutics | 0.1 | $15M | 1.4M | 10.58 | |
| Audentes Therapeutics | 0.1 | $15M | 393k | 38.21 | |
| Biomarin Pharma Inc convertible/ | 0.1 | $15M | 15M | 1.01 | |
| Neurocrine Biosciences Inc Note 2.250 5/1 | 0.1 | $15M | 10M | 1.45 | |
| Biomarin Pharmaceutical Inc note 0.750%10/1 | 0.1 | $13M | 12M | 1.06 | |
| Exelixis (EXEL) | 0.1 | $11M | 513k | 21.52 | |
| Catalyst Pharmaceutical Partners (CPRX) | 0.1 | $11M | 3.6M | 3.12 | |
| Corsicanto Ii Designated Act note | 0.1 | $11M | 10M | 1.09 | |
| Albireo Pharma | 0.1 | $8.9M | 250k | 35.50 | |
| Progenics Pharmaceuticals | 0.1 | $7.9M | 979k | 8.04 | |
| Acceleron Pharma | 0.1 | $8.0M | 164k | 48.52 | |
| Galmed Pharmaceuticals | 0.1 | $7.6M | 636k | 11.90 | |
| Foamix Pharmaceuticals | 0.1 | $7.5M | 1.5M | 5.01 | |
| G1 Therapeutics (GTHX) | 0.1 | $7.4M | 170k | 43.46 | |
| Inflarx Nv (IFRX) | 0.1 | $8.3M | 259k | 32.25 | |
| Momenta Pharmaceuticals | 0.1 | $6.3M | 309k | 20.45 | |
| Aegerion Pharmaceuticals 2% Du cvbond | 0.1 | $6.0M | 9.5M | 0.63 | |
| Autolus Therapeutics Plc spon ads (AUTL) | 0.1 | $6.3M | 235k | 26.79 | |
| Vanda Pharmaceuticals (VNDA) | 0.0 | $5.9M | 310k | 19.05 | |
| Acorda Therapeutics | 0.0 | $5.0M | 173k | 28.70 | |
| Achillion Pharmaceuticals | 0.0 | $5.5M | 1.9M | 2.83 | |
| Chemocentryx | 0.0 | $5.5M | 414k | 13.17 | |
| Versartis | 0.0 | $4.9M | 2.4M | 2.02 | |
| Glycomimetics (GLYC) | 0.0 | $4.7M | 291k | 16.13 | |
| Assembly Biosciences | 0.0 | $5.8M | 149k | 39.21 | |
| Syros Pharmaceuticals | 0.0 | $5.9M | 575k | 10.21 | |
| Anaptysbio Inc Common (ANAB) | 0.0 | $5.2M | 73k | 71.04 | |
| Menlo Therapeutics | 0.0 | $5.7M | 700k | 8.12 | |
| Sesen Bio | 0.0 | $5.1M | 2.6M | 1.95 | |
| Alkermes (ALKS) | 0.0 | $4.1M | 100k | 41.16 | |
| Tetraphase Pharmaceuticals | 0.0 | $3.3M | 935k | 3.57 | |
| Macrogenics (MGNX) | 0.0 | $4.5M | 218k | 20.65 | |
| Aerie Pharmaceuticals | 0.0 | $4.1M | 60k | 67.54 | |
| La Jolla Pharmaceuticl Com Par | 0.0 | $4.5M | 155k | 29.17 | |
| Adamas Pharmaceuticals | 0.0 | $4.5M | 173k | 25.83 | |
| Natera (NTRA) | 0.0 | $4.3M | 229k | 18.82 | |
| Spring Bk Pharmaceuticals In | 0.0 | $4.4M | 373k | 11.85 | |
| Aevi Genomic | 0.0 | $4.5M | 4.1M | 1.11 | |
| Apellis Pharmaceuticals (APLS) | 0.0 | $4.3M | 196k | 22.00 | |
| Forty Seven | 0.0 | $4.0M | 250k | 16.00 | |
| Rigel Pharmaceuticals (RIGL) | 0.0 | $2.9M | 1.0M | 2.83 | |
| Newlink Genetics Corporation | 0.0 | $2.4M | 507k | 4.76 | |
| Trillium Therapeutics, Inc. Cmn | 0.0 | $3.1M | 512k | 6.00 | |
| Tonix Pharmaceuticals Hldg C | 0.0 | $3.1M | 700k | 4.45 | |
| Nabriva Therapeutics | 0.0 | $3.3M | 938k | 3.48 | |
| Krystal Biotech (KRYS) | 0.0 | $3.0M | 200k | 14.87 | |
| Infinity Pharmaceuticals (INFIQ) | 0.0 | $1.1M | 580k | 1.91 | |
| D Stemline Therapeutics | 0.0 | $715k | 45k | 16.06 | |
| Trevena | 0.0 | $1.4M | 950k | 1.44 | |
| Mediwound Ltd cmn | 0.0 | $1.6M | 226k | 6.90 | |
| T2 Biosystems | 0.0 | $774k | 100k | 7.74 | |
| Dynavax Technologies (DVAX) | 0.0 | $1.1M | 75k | 15.25 | |
| Proteon Therapeutics | 0.0 | $732k | 299k | 2.45 | |
| Cellectis S A (CLLS) | 0.0 | $1.4M | 50k | 28.30 | |
| Adaptimmune Therapeutics (ADAP) | 0.0 | $1.2M | 100k | 11.87 | |
| Corbus Pharmaceuticals Hldgs | 0.0 | $1.2M | 248k | 5.05 | |
| Arbutus Biopharma (ABUS) | 0.0 | $1.3M | 181k | 7.30 | |
| Selecta Biosciences (RNAC) | 0.0 | $1.2M | 94k | 13.25 | |
| Sunesis Pharmaceuticals Inc Ne | 0.0 | $1.2M | 557k | 2.12 | |
| Ra Pharmaceuticals | 0.0 | $1.8M | 178k | 9.95 | |
| Jounce Therapeutics | 0.0 | $766k | 100k | 7.66 | |
| Ovid Therapeutics (OVID) | 0.0 | $1.9M | 248k | 7.80 | |
| Arcus Biosciences Incorporated (RCUS) | 0.0 | $1.5M | 122k | 12.24 | |
| Ritter Pharmaceuticals | 0.0 | $720k | 280k | 2.57 | |
| BioDelivery Sciences International | 0.0 | $620k | 210k | 2.95 | |
| Cyclacel Pharmaceuticals Inc pfd conv ex 6% (CYCCP) | 0.0 | $89k | 13k | 6.72 | |
| Affimed Therapeutics B V | 0.0 | $660k | 400k | 1.65 | |
| Biotime Inc wts oct 1 18 | 0.0 | $1.0k | 20k | 0.05 | |
| Akari Therapeutics | 0.0 | $115k | 59k | 1.96 | |
| Fulgent Genetics (FLGT) | 0.0 | $518k | 125k | 4.14 | |
| Molecular Templates | 0.0 | $379k | 72k | 5.23 |
